Literature DB >> 15760677

Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production.

Hitoshi Takahashi1, Makiko Kobayashi, Yasuhiro Tsuda, David N Herndon, Fujio Suzuki.   

Abstract

Previously, we have reported that the susceptibility of burned patients to infectious complications is increased when the production of CC-chemokine ligand 3 (CCL3) is impaired. In this study, the role of the sympathetic nervous system on impaired CCL3 production and antibacterial resistance following burn injuries was investigated. Normal mice were resistant (65% survival) to cecal ligation and puncture (CLP)-induced sepsis, while the same CLP killed 90% of thermally injured mice (TI-mice). However, TI-mice resisted CLP-induced sepsis (60% survival) when they were previously treated with CCL3 or sympathectomized with 6-hydroxydopamine (6-OHDA). Augmentation of host resistance against CLP-induced sepsis by 6-OHDA was abrogated by anti-CCL3 mAb treatment. Norepinephrine (NE) production was increased in circulation of TI-mice, and treatment of TI-mice with 6-OHDA resulted in the inhibition of NE secretion. CCL3 production was impaired in cultures of T cells from TI-mice or normal T cells treated with NE, even when stimulated with anti-CD3 mAb. However, CCL3 was produced by mAb-stimulated T cells from TI-mice previously treated with 6-OHDA. These results indicated that by inhibiting CCL3 production the sympathetic nervous system contributes to the increased susceptibility of TI-mice to sepsis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760677     DOI: 10.1016/j.cyto.2004.10.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

Review 2.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

3.  Extent and magnitude of catecholamine surge in pediatric burned patients.

Authors:  Gabriela A Kulp; David N Herndon; Jong O Lee; Oscar E Suman; Marc G Jeschke
Journal:  Shock       Date:  2010-04       Impact factor: 3.454

4.  Repeated Stress Exaggerates Lipopolysaccharide-Induced Inflammatory Response in the Rat Spleen.

Authors:  M Laukova; Peter Vargovic; I Rokytova; G Manz; R Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

5.  Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study.

Authors:  Steffen Christensen; Martin Berg Johansen; Else Tønnesen; Anders Larsson; Lars Pedersen; Stanley Lemeshow; Henrik Toft Sørensen
Journal:  Crit Care       Date:  2011-03-07       Impact factor: 9.097

6.  Beta blockade in TBI: Dose-dependent reductions in BBB leukocyte mobilization and permeability in vivo.

Authors:  Alfonso J Lopez; Mohamed ElSaadani; Christina L Jacovides; Anastasia Georges; Matthew C Culkin; Syed Ahmed; Monisha A Kumar; Lewis J Kaplan; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2022-01-18       Impact factor: 3.697

7.  The Cholinergic and Adrenergic Autocrine Signaling Pathway Mediates Immunomodulation in Oyster Crassostrea gigas.

Authors:  Zhaoqun Liu; Lingling Wang; Zhao Lv; Zhi Zhou; Weilin Wang; Meijia Li; Qilin Yi; Limei Qiu; Linsheng Song
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.